Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$84,298,255
+$61,285,473 QoQ
Shares Held
561,876
+125.5% QoQ
Ownership
0.419%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#54
of 594 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SAMLYN CAPITAL, LLC holds $115,394,460 across 2 Diagnostics & Research names. GH ranks #1 (73.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
561,876 | $84,298,255 | |
| 2 | NEO |
Neogenomics Inc
|
2,131,337 | $31,096,205 |
All Filings in GH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,298,255 | 561,876 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $23,012,782 | 249,137 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||